Sanofi To Advance Kymera’s IRAK4 Protein Degrader After Phase I Success

But Some Analysts Advise Caution

 
• By Ayisha Sharma
  
Man pressing elevator button
Kymera Has Bounced Back From A Previous Safety Concern • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapy Areas